The landscape of T-cell engagers for the treatment of follicular lymphoma by Alfredo Rivas-Delgado, Ivan Landego, Lorenzo Falchi

Get full text

BCR SIGNALING INHIBITORS: AN OVERVIEW OF TOXICITIES ASSOCIATED WITH IBRUTINIB AND IDELALISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA by Lorenzo Falchi, Jessica M Baron, Carrie Anne Orlikowski, Alessandra Ferrajoli

Get full text

Two decades of single-institution data reveal rare long-term survivors of relapsed/refractory Burkitt lymphoma by Rabeya Molla, Kurt Bantilan, Ellin Berman, Philip Caron, Lorenzo Falchi, Paul Hamlin, Steven Horwitz, Andrew Intlekofer, Anita Kumar, Jennifer Lue, Alison Moskowitz, Colette Owens, Maria Lia Palomba, Parastoo Bahrami Dahi, Gilles Salles, Santosha Vardhana, Gunjan Shah, Andrew Zelenetz, William Johnson, Ariela Noy

Get full text

Humoral vaccine responses following Chimeric Antigen Receptor T-cell therapy for hematological malignancies by Sigrun Einarsdottir, Stephanie Lobaugh, Danny Luan, Marina Gomez-Llobell, Padmapriya Subramanian, Sean Devlin, David Chung, Parastoo B. Dahi, Lorenzo Falchi, Sergio Giralt, Heather Landau, Alexander M. Lesokhin, Richard Lin, Jennifer Lue, Sham Mailankody, M. Lia Palomba, Jae H. Park, Gilles Salles, Michael Scordo, Silvia Escribano-Serrat, Jaime Sanz, Kai Rejeski, Roni Shouval, Saad Usmani, Miguel-Angel Perales, Gunjan Shah, Zainab Shahid

Get full text